ImmunoRec is a University of Crete spin-off Biotech Company.
Our Implantable Cell Therapy Platform technology is the offspring of a 15-year research, with 2 major therapeutic applications:
• Fully Personalized Treatment against Solid tumors
• Anti-virus prophylactic vaccination
ImmunoRec’s groundbreaking technology of implantable combined Advanced Therapy Medicinal Product (cATMP) leads to the in vivo formation of a non-biodegraded, sustainable, vascularized Artificial Functional Lymph Node.
